LATANOPROST/TIMOLOL APOTEX
0,05MG/ML+5MG/ML OPH GTT SOL 1X2,5ML
| SÚKL code | 0182267 |
|---|---|
| Name of the product | LATANOPROST/TIMOLOL APOTEX |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | LATANOPROST/TIMOLOL APOTEX |
| Supplement | 0,05MG/ML+5MG/ML OPH GTT SOL 1X2,5ML |
| Strenght | 0,05MG/ML+5MG/ML |
| Pharmaceutical form | Eye drops, solution |
| Package | 1X2,5ML |
| Route | Ocular use |
| Language of the pack | Czech |
| Wrap type | Dropper container |
| Legal status | na lékařský předpis |
| Active substance |
TIMOLOL MALEATE (TIMOLOLI MALEAS) LATANOPROST (LATANOPROSTUM) |
| ATC group | S01ED51 |
| ATC group name | TIMOLOL, KOMBINACE |
| Doping | Beta-blokátory (zakázány pouze při soutěži v určitých sportech). Bližší informace viz www.antidoping.cz/cs/zakazane-leky |
Marketing authorisation information
| Registration Number | 64/ 134/12-C |
|---|---|
| Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Reference member state |
| MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
| Placed on the market till | 31. 08. 2020 |
| MA Holder | Apotex Europe B.V., Leiden |
| MA Holder country | NIZOZEMSKO |
| Actual MA holder | Aurovitas, spol. s r.o., Praha |
| Actual MA holder country | ČESKÁ REPUBLIKA |
cz